Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
NCT02522611
Cancer Pain, Intractable Pain
Bethesda, Maryland, United States
View Trial DetailsNCT Number: NCT07427550
The current study aims to investigate the potential impact of the proposed Assisted Dying (Terminally Ill Adults (2024) Bill on Palliative care workers. Palliative care professionals across the Humber Health Partnership will be interviewed using semi-structured interview questions, with the intention of exploring the way they make sense of the potential implementation of the bill, particularly in relation to their professional identity. The research will be carried out in line with guidance for Interpretative Phenomenological Analysis (Smith, Flowers & Larkin, 2021), a research methodology which aims to explore how people make sense of their experience, often in response to a particular event.
It is hoped that the study will contribute to the ongoing discussions regarding how the bill should be implemented and offer potential insights into ways that hospitals may best support staff during the passing of the bill into law. The study will be sponsored by Hull University Teaching Hospitals Trust (HUTH).
Trial opening soon.
Get Notified18 year–80 year
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Taken at the point of interview, two weeks after recruitment.
Thematic representations of participant's experiential accounts.
Contact information is provided by the study sponsor or research team.
Hull University Teaching Hospitals NHS Trust
Other Gov
The Potential Impact of the Terminally Ill Adults (End of Life) Bill on the Professional Identity of Palliative Care Staff
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02522611
Cancer Pain, Intractable Pain
Bethesda, Maryland, United States
View Trial DetailsNCT07737899
Advanced Cancer, Chronic Disease
Coimbra, Portugal
View Trial DetailsNCT07692711
Generative Artificial Intelligence, Natural Language Processing (NLP)
Taipei, Taiwan
View Trial DetailsNCT07674797
Electronic Assessments, Neoplasms
Houston, Texas, United States
View Trial Details